| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |